drugset / Trial / NCT00133458

RCT ALB for SA Cysticercosis

NCT00133458

RandomizedParallel-groupDouble-blindTreatment

Summary

This study will enroll 120 individuals diagnosed with subarachnoid cysticercosis, a disease caused by the invasion of the basal part of your brain by a parasite named Taenia solium. Subarachnoid cysticercosis is usually treated with albendazole for one month to kill the parasite. This study will determine if two months of albendazole (ABZ) therapy is better than one-month. The study will last 3 years.

Timeline

Start
Primary completion
Completion
2007-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Albendazole Small molecule

Indications